material misstatement

Rosen Law Firm files securities class action against REGENXBIO for alleged false statements on product safety and efficacy, with April 14, 2026 lead plaintiff deadline.

Class action lawsuit filed against $QURE over alleged misstatements about Huntington's disease therapy approval timeline. Stock crashed 49% after FDA stance shift.

PayPal faces securities class action lawsuit alleging misleading statements about 2027 financial targets and Branded Checkout growth potential. Eligible shareholders have until April 20, 2026 deadline to secure counsel.

Driven Brands ($DRVN) faces class action lawsuit over accounting errors in fiscal 2023-2025 statements. Stock fell 40% after February disclosure. Investors can seek lead plaintiff status.

Class action lawsuit filed against $METC alleges executives made false statements about Brook Mine development progress. Investors from July-October 2025 urged to participate.

Securities class action lawsuit filed against Apollo Global Management over alleged undisclosed communications with Jeffrey Epstein. Shareholders may join by May 1, 2026 deadline.

Ostin Technology faces class action lawsuit alleging false statements and undisclosed conspiracy to artificially inflate stock price. Lead plaintiff deadline set for April 17, 2026.

Law firm launches securities fraud class action against $FBRT, alleging reckless overstatement of dividend sustainability between November 2024 and February 2026.

Johnson Fistel investigates Hub Group after accounting error disclosure causes stock decline. Company restated 2025 quarterly financials over understated transportation costs.

Class action lawsuits filed against Paysafe and Oracle alleging material disclosure failures. Paysafe stock fell 27.6% on undisclosed risks; Oracle faces allegations over understated AI CapEx requirements.

Securities class action filed against $PYPL alleging false statements on 2027 financial targets and Branded Checkout growth. Lead plaintiff deadline April 20, 2026.

The Gross Law Firm files class action against $KD over alleged materially false statements, inadequate internal controls, and delayed Q4 2025 filing.

Securities fraud class actions filed against PayPal, NuScale, Corcept, and Navan. Investors must file lead plaintiff motions by April 20-24, 2026.

Class action lawsuit filed against $QURE over alleged misstatements about AMT-130 gene therapy FDA approval status. Stock plunged 49% after FDA reversed position on Phase I/II data adequacy.

Vistagen faces securities fraud lawsuit over fasedienol trial misstatements. Affected investors have until March 16, 2026 deadline to seek lead plaintiff status or secure counsel.

Kahn Swick & Foti, LLC filed class action lawsuits against Navan, Kyndryl, and Ultragenyx for alleged securities disclosure violations. Lead plaintiff applications due April 24, 2026.

CoreWeave faces class action securities fraud lawsuit alleging overstatement of capacity and understatement of supplier risks between March-December 2025. Lead plaintiff applications due March 13, 2026.

Class action lawsuit filed against $FBRT for allegedly misleading investors about dividend sustainability. Stock plunged 14.2% after February disclosure of capital over-distribution.

Beyond Meat faces securities class action over asset valuation disclosures spanning Feb-Nov 2025. Lead plaintiff deadline March 24, 2026.

Franklin BSP Realty Trust faces class action lawsuit over allegedly false dividend sustainability claims, affecting investors from November 2024 through February 2026.